Harmony’s CFO & The Art of Timely Disposals

A modest sum, perhaps, in the grand scheme of pharmaceutical fortunes. Though, as any seasoned investor knows, it’s not the size of the slice, but the quality of the pie. The weighted average purchase price, a mere $37.15 per share, suggests a degree of foresight. A man who buys low and sells… well, at a reasonable price, is a man to be reckoned with.

The Illusion of Access

The practice, once commonplace, receded into a quiet obsolescence, only to re-emerge, not as a testament to growth, but as a symptom of a peculiar societal anxiety. The elevated price of a share becomes, in itself, a barrier, a gate kept by an unseen bureaucrat. The split, then, is not an opening of the gate, but the creation of a larger number of smaller, equally illusory keys.

Scholar Rock: A Modest Disbursement

Values derived from the SEC Form 4’s weighted average purchase price of $46.71. Post-transaction valuations, of course, are subject to the whims of the market, a capricious mistress indeed, and calculated using the January 22nd, 2026 closing price.

Beyond Meat: A Fading Bloom

One approaches this enterprise, this Beyond Meat, with a certain melancholy. It seemed, for a time, a herald of a new sensibility, a response to the age’s anxieties about sustenance and the earth. But now, gazing upon its performance, one is compelled to ask: what has become of that initial fervor?

Nio: A Descent into the Chinese Automotive Abyss

The rise of the “new energy vehicle” – the electric car and its hybrid kin – has been remarkable. By the first half of 2025, these vehicles comprised over half of all new car sales in China. A revolution, some proclaimed. A bubble, others muttered. The truth, as always, is likely a tortured compromise between the two. It naturally followed, then, that companies like Nio, purveyors of these futuristic machines, would be ripe for investment. A tempting proposition, to pluck a share for less than five dollars. But the market, my friends, is rarely so… straightforward.

Brookfield Renewable: A Most Promising Venture

The outlook, as far as one can tell, is exceedingly bright. They anticipate continued brisk growth for years to come, positioning them rather splendidly to generate powerful total returns for investors. A truly fortunate state of affairs, wouldn’t you agree?

Molina’s Tax Sale: Really?

And the market just ate this up. The stock barely blinked. Which is… infuriating. It’s like, you can’t even get a little volatility out of a sizable insider sale? What is happening with market efficiency? It’s all algorithms and high-frequency trading. No one’s actually thinking anymore. Just reacting. And they’re rewarding this… this blatant display of fiscal clumsiness.

Netflix: Still Funny After All These Years

So, they’re making TV shows, movies… all that expensive stuff. Billions, folks! Eighteen billion smackers last year just for content. That’s enough to buy a small country, or at least a really nice golf course. But now, they’re dabbling in… podcasts? It’s like the Roman Empire deciding to open a bakery. Unexpected, but potentially brilliant. They’re snagging podcasts from Spotify, iHeartMedia, even Barstool Sports. Barstool! The things I’ve seen… It’s a long list, and it’s cheaper than hiring another A-list actor who demands a private jet filled with avocado toast.